IGHD patients have a significant increase in visceral fat (52), but IS is increased in relation to age, sex and BMI matched control group when evaluated by HOMA-IR and similar to control group when assessed by glucose and insulin curves from GTT, clearly showing that patients with IGHD do not have insulin resistance (53). The gene discussed is INS; the disease is isolated congenital growth hormone deficiency.